glp-1 and substance use disorder receptor agonists are promising but unproven treatments for alcohol disorders IUPHAR review – Glucagon-like peptide-1
Description
They were originally developed for management of type 2 diabetes, but have since become a common treatment for weight management within the UK
Is it purely glucose control
A., Rajasekeran, H., Lytvyn, Y., Lovblom, L
George Engel, who recognized that health and illness are not just the result of biological factors but are also influenced by psychological and social factors
